Izicopan, InflaRx’s experimental oral therapy for ANCA-associated vasculitis (AAV), was shown to reduce kidney damage in two different animal models of kidney injury. That’s according to data presented in a poster at the American Society of Nephrology’s Kidney Week 2026, held Oct. 21-25 in Denver. The poster was…
Discussion
I have been watching the WNBA this season with the kind of attention I used to save for things I was pretty sure would change me. And it has. There is something remarkable about watching athletes who are becoming. Not finished, not polished into a final form, but visibly, beautifully…
Discussion
Older age and poorer kidney function at diagnosis are each linked to a higher risk of death among people with ANCA-associated vasculitis (AAV), a real-world study in Turkey found. These two factors, as well as lung involvement and heart involvement, were found to be independent predictors of death within…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
